New Test Predicts Which Senolytic Drugs Will Work for Individual Patients
Researchers develop BH3 profiling to predict senolytic drug effectiveness, moving beyond one-size-fits-all aging treatments.
1529 articles in this topic
Researchers develop BH3 profiling to predict senolytic drug effectiveness, moving beyond one-size-fits-all aging treatments.
Comprehensive review compares natural compounds, synthetic drugs, and exercise for combating age-related bone loss, muscle weakness, and joint degeneration.
First clinical trial of NAD+ precursor in Werner syndrome patients shows improved arterial stiffness and reduced skin ulcers with no serious side effects.
Comprehensive review finds limited human data supporting off-label rapamycin use for healthy aging despite strong animal studies.
Revolutionary thermoelectric hydrogels convert body heat to electricity, dramatically speeding wound closure through cellular stimulation.
New review reveals how nerve signals, Schwann cells, and nerve-derived cells orchestrate tissue healing and regeneration.
Head-to-head comparison shows bioMΓ©rieux's latest MALDI-TOF system delivers comparable accuracy with workflow advantages for high-volume labs.
New manifesto outlines how digital twin technology could revolutionize pathology workflows, reducing diagnostic errors by up to 90% and cutting turnaround times.
New research reveals how protein S-glutathionylation acts as a cellular defense mechanism against ferroptosis when glutathione levels drop.
Scientists discover GSK3Ξ²-mediated pathway that could treat kidney disease more safely than current Nrf2 therapies.
Study reveals both conditions impair muscle oxygen extraction by similar amounts, suggesting shared therapeutic targets.
New minimally invasive techniques for thyroid cancer surgery offer better cosmetic outcomes and faster healing compared to traditional open surgery.